Indivior Pharmaceuticals Inc
INDV
Clasificación en acciones
#3829
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Precio por acción
$34.70
Última sincronización: 2026-10-21
Capitalización bursátil
$4.33B
Cambio (1 día)
-0.20%
Cambio (1 año)
39.36%
País
US
Comercio Indivior Pharmaceuticals Inc (INDV)
Categoría
Healthcare
Historial del precio de la acción de Indivior Pharmaceuticals Inc (INDV)
Precio más alto de cierre: $35.03 el 2026-10-01
Precio más bajo de cierre: $10.90 el 2014-12-01
Precio más bajo de cierre: $10.90 el 2014-12-01
Historial del precio de la acción de Indivior Pharmaceuticals Inc desde 2014 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | -1.35% |
| 2025 | 202.98% |
| 2024 | -23.97% |
| 2023 | -28.64% |
| 2022 | 35.86% |
| 2021 | 132.41% |
| 2020 | 154.62% |
| 2019 | -56.62% |
| 2018 | -76.25% |
| 2017 | 41.62% |
| 2016 | 30.92% |
| 2015 | 29.04% |
| 2014 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.30 | 42.57% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $19.19 | -0.09% |
IN
|
